Endo's Third Quarter Meets Our Expectations as Company Continues to Face Challenges
Endo continues to face significant challenges, in our view, but the company reported third-quarter results mostly in line with our expectations as management also reaffirmed its year-end outlook. We don’t anticipate a change to our fair value estimate for now, but we continue to have long-term concerns over Endo’s relatively weak competitive position, which is reflected in our no-moat rating.Endo’s third quarter showed consistent headwinds in both its branded and generic drug segments, with st...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.